Evidence map›Paper›PMID 39684960›Full record

ArticleHealthcare (Basel, Switzerland)2024

Understanding the Landscape of Cancer Care in Europe: Evaluating Clinical and Comprehensive Cancer Centers.

Denis Horgan, Marc Van den Bulcke, Núria Malats, Ruggero de Maria, France Dube, Jaya Singh, Paul Hofman, Muhammad Imran Omar, Umberto Malapelle, Tanya Hills and 2 more

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Denis HorganEuropean Alliance for Personalised Medicine, 1040 Brussels, Belgium.ORCID 0000-0003-4392-4505
Marc Van den BulckeBelgian Cancer Centre, Sciensano, 1050 Brussels, Belgium.
Núria MalatsGenetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.ORCID 0000-0003-2538-3784
Ruggero de MariaInstitute of General Pathology, Catholic University of the Sacred Heart, 20123 Rome, Italy.
France DubeAstra Zeneca, Concord Pike, Wilmington, DE 19803, USA.
Jaya SinghEuropean Alliance for Personalised Medicine, 1040 Brussels, Belgium.
Paul HofmanLaboratory of Clinical and Experimental Pathology, IHU RespirERA, FHU-OncoAge, Côte d'Azur University, 06000 Nice, France.ORCID 0000-0003-0431-9353
Muhammad Imran OmarEuropean Association of Urology, Research Fellow Academic Urology Unit, University of Aberdeen, Aberdeen AB25 2ZD, UK.ORCID 0000-0002-1597-3126
Umberto MalapelleDepartment of Public Health, University Federico II of Naples, 80138 Naples, Italy.ORCID 0000-0003-3211-9957
Tanya HillsBoehringer Ingelheim International GmbH, 55218 Ingelheim am Rhein, Germany.
Francesco PepeDepartment of Public Health, University Federico II of Naples, 80138 Naples, Italy.ORCID 0000-0002-2803-9586
Vivek SubbiahSarah Cannon Research Institute, Nashville, TN 37203, USA.

Funding

CAN.HEAL project through the European Commission EU4Health Program 2021-2027 101080009
6 · The paper itself

Abstract

backgroundA comparison of the operations of Clinical Cancer Centers and Comprehensive Cancer Centers across Europe provides novel data on the interrelation between different factors in care delivery.

methodThe analysis is based on a survey of key dimensions in care delivery, comparing routine treatment, advanced technology integration, research participation, and innovation adoption across the two types of centers.

resultsClinical Cancer Centers excel in providing routine cancer treatment through multidisciplinary teams but struggle with advanced technology integration and research participation. In contrast, Comprehensive Cancer Centers offer robust infrastructure and focus on research, advanced diagnostics, and innovative therapies, yet they face challenges in fully integrating these technologies into patient care.

conclusionCollaboration between the two types of centers could enhance overall cancer care effectiveness, leveraging the routine efficiency of Clinical Centers and the innovative capabilities of Comprehensive Centers. By addressing gaps in technology adoption, supportive care integration, and research involvement, a more holistic cancer care network can be established, ensuring that patients across Europe access both foundational care and the latest therapeutic options.

Indexed as

clinical cancer centerscomprehensive cancer centershealthcare deliveryinnovation in healthcareoncological care

Identifiers

PMID39684960
PMCPMC11640883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.